The IARC evaluates evidence from epidemiological studies, animal research, and mechanistic data. The assessment process involves a comprehensive review of available scientific studies to determine the consistency and strength of the evidence linking the agent to cancer. A Group 1 classification typically requires strong and consistent evidence from human studies.
